0      0

2020 ISPE Annual Meeting & Expo


SES406 - Make vs. Buy Business Analysis in Advanced Therapies


Nov 6, 2020 9:00am ‐ Nov 6, 2020 10:30am

Description

In a moderated panel discussion, Project Farma details the considerations used in determining whether an advanced therapy company should manufacture therapies internally or utilize external third-party manufacturers. This discussion explores the rationale of gene and cell therapy companies using an external CMO or relying on internal manufacturing. With insight from one advanced therapy company that utilizes third party manufacturing, and another that manufactures internally, Project Farma provides the considerations for both cases along with perspective from a CMO regarding external manufacturing.

Session Leader(s):

Speaker(s):

Panelist(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content